An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive Disorder
Jon E. Grant, Sophia Boutouis, Margaret O’Brien, Laurie Avila, Megha Neelapu, Dustin Ehsan
Clinical Neuropharmacology · 2026
10.1097/wnf.0000000000000683